Crossmark

<scp>CDK</scp> 12 drives breast tumor initiation and trastuzumab resistance via <scp>WNT</scp> and <scp>IRS</scp> 1‐ErbB‐ <scp>PI</scp> 3K signaling

Published Online: 2019-08-30

Published Print: 2019-10-04

Authors

Choi, Hee‐Joo

Jin, Sora

Cho, Hani

Won, Hee‐Young

An, Hee Woon

Jeong, Ga‐Young

Park, Young‐Un

Kim, Hyung‐Yong

Park, Mi Kyung

Son, Taekwon

Min, Kyueng‐Whan https://orcid.org/0000-0002-4757-9211
Jang, Ki‐Seok

Oh, Young‐Ha

Lee, Jeong‐Yeon https://orcid.org/0000-0003-1298-7466
Kong, Gu https://orcid.org/0000-0001-9206-8210
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2019R1A2C3006305)
License Information

Version of Record valid from 2019-08-30
More Information

Publication History

Received: 2019-03-08

Accepted: 2019-08-09

Published: 2019-08-30

Document is current